Skip to main content
Clinical Trials/NCT02844712
NCT02844712TerminatedNot Applicable

Negative Predictive Value of Drug Provocation Tests to Beta-lactams

University Hospital, Montpellier1 site in 1 country750 target enrollmentStarted: December 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
750
Locations
1
Primary Endpoint
Negative predictive value of drug provocation tests to betalactams

Study Overview

Brief Summary

Patients with a complete drug allergy work-up to betalactam antibiotics were contacted (by mail) and asked to answer a questionnaire regarding the tolerance upon readministration of a negatively tested beta-lactam.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
5 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Elderly patients with at least 5 years at the time of consultation for allergy suspected allergy to beta-lactam antibiotics in the University Hospital of Montpellier and with a negative provocation test to a betalactam
  • •The patient or the patient's legal representatives are not their opposition to participate in this study
  • •The patient must be affiliated or beneficiary in a health insurance system

Exclusion Criteria

  • •The patient is exclusion period determined by a previous study
  • •The patient is under judicial protection, guardianship or curatorship
  • •The patient or the patient's legal representatives do not read fluently the French language

Arms & Interventions

Evaluation of reexposure to a negatively tested betalactam

Other

Intervention: Evaluation of reexposure to a negatively tested betalactam (Other)

Outcomes

Primary Outcomes

Negative predictive value of drug provocation tests to betalactams

Time Frame: one day

Secondary Outcomes

  • The types of reactions upon reexposure to a negatively tested betalactam(one day)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials